KR20220116785A - Cosmetic composition comprising mixed fermented extract of medicinal plants (Phytoestrogenbiom) as an active ingredient - Google Patents

Abstract

The present invention relates to a skin anti-aging functional cosmetic composition, which contains a fermented extract of Actaea racemosa, Angelica gigas, Cornus officinalis, Medicago sativa and Phyllanthus emblica. The cosmetic composition of the present invention increases the content of total phenols and total flavonoids as well as ellagic acid, which is one of plant estrogen components, and has an excellent antioxidant effect and an excellent skin improving effect through inhibition of skin damage caused by UV rays and increased production of hyaluronic acid, thereby being provided as an anti-aging cosmetic composition.

Description

Cosmetic composition comprising mixed fermented extract of medicinal plants (Phytoestrogenbiom) as an active ingredient

The present invention relates to a cosmetic composition comprising a medicinal plant mixture ferment extract, and more particularly, to a cosmetic composition having anti-aging and skin improvement effects using the fermented medicinal plant mixture extract as an active ingredient.

Skin aging is divided into natural aging and photoaging. As the skin ages, it becomes thin, dry and wrinkled. Although normal epidermal differentiation occurs in aged skin, it becomes thinner due to reduced division of keratinocytes, and the dermis also becomes thinner due to reduction of connective tissue. Repeated UV exposure increases the skin's matrix metalloproteinases (MMPs), and the increased MMPs promote the breakdown of collagen in the skin to form wrinkles. In women, the accelerated skin aging after menopause is influenced by a deficiency of hormones such as estrogen. Estrogen deficiency not only accelerates natural aging, but also accelerates skin aging caused by UV rays and other environmental factors, so supplementation and maintenance of estrogen is an important key to skin health and anti-aging.

Methods of supplementing estrogen include supplementation therapy that supplements female hormones and a method using phytoestrogens. Hormone replacement therapy is known to relieve vasomotor symptoms and mental and psychological symptoms of early menopause, prevent atrophy of the genital organs and skin, and protect bones and cardiovascular systems. However, the National Institutes of Health in 2002 pointed out that hormone replacement therapy can cause heart disease and stroke, and a study that long-term use of estrogen and progestin significantly increases the risk of breast cancer (JAMA, 2010;304 (JAMA, 2010;304). 15):1684-92), and there is controversy over its effectiveness. On the other hand, using phytoestrogens has the advantage of not having side effects such as breast cancer and being simple to consume.

Phytoestrogens are plant-derived components that are not produced in the endocrine system, but are obtained by ingesting phytoestrogens plants. Phytoestrogens are naturally occurring nonsteroidal compounds that have a structure similar to Estradiol (17-β-estradiol) and bind to the estrogen receptor, acting as an agonist or antagonist for estrogen (Yildiz F (2005), ISBN 978- 1-57444-508-4) Phytoestrogens exist in more than 500 species of plants, including fruits and vegetables (Lee, Seon-haeng (2015) ISSN 2287-9463), largely isoflavones, Flavanones, Flavonoids, Plant sterols, Coumestans, Stibens, lignans, and family (Michelle Mostrom, ISBN:978-0-12-382032-7). Isoflavone substances such as Daidzein and Genistein are mainly found in legumes, lignans substances such as Secoisolariciresinol are found in flaxseed, legumes, corn, fruits and vegetables, and coumestan substances such as Coumestrol are mainly found in germination stage plants. . In addition, polyphenol-based substances such as ellagic acid are present in pomegranates and strawberries (P Moutsatsou, Hormones, 2007, 6(3): 173-193) Phytoestrogens are effective for menopause, osteoporosis and skin improvement, and improve skin In relation to this, it is known that soybean, which contains a lot of isoflavones, one of the phytoestrogens, is effective for skin improvement by inhibiting the synthesis of MMPs in the skin and promoting the synthesis of collagen (Varani J., 2000, J. Invest Dermatol, 114). : 480-486).

The skin plays a role in protecting our body from external harmful factors. Ultraviolet (UV) is a harmful factor that is directly transmitted to the skin and is classified into UVA (320-400 nm), UVB (290-320 nm), and UVC (200-290 nm) depending on the length of the wavelength. UVA and UVB either directly damage DNA or generate reactive oxygen species, thereby accelerating skin aging such as loss of skin elasticity and wrinkle formation. In particular, when the keratinocytes present in the epidermis of the skin are exposed to ultraviolet light, the expression of aquaporin 3 protein that transports water into cells and HAS2 (hyaluronan synthase 2), an enzyme that produces hyaluronic acid (HA), is reduced. Drying is caused. Hyaluronic acid is a water-soluble polysaccharide with high viscosity and moisturizing properties, and is involved in moisture retention in skin tissue, storage and diffusion of cell growth factors and nutrients.

As a prior art for increasing skin hyaluronic acid, Korean Patent Publication No. 10-2019-0104470 discloses a composition for preventing or improving skin wrinkles including a fermented herbal extract. This relates to a cosmetic composition for preventing or improving skin wrinkles by fermenting extracts of Sukjihwang, astragalus, green tea, peony, cornflower oil, galgeun, omija, angelica, chrysanthemum, cinnamon, magnolia, and pig placenta. Thus, the effect of increasing hyaluronic acid is achieved.

However, in recent years, as more and more consumers avoid cosmetics containing animal ingredients and seek safe products and healthy ingredients from an animal protection and environmental point of view, there is a technology that can effectively increase skin hyaluronic acid using natural plant materials. demand is increasing.

Numerous references are referenced throughout this specification and citations thereof are indicated. The disclosures of the cited documents are hereby incorporated by reference in their entirety to more clearly set forth the content of the present invention and the level of the art to which the present invention pertains.

Republic of Korea Patent Publication No. 10-2019-0104470

An object of the present invention is to use a fermented extract of a medicinal plant mixture as an active ingredient to increase total phenol and total flavonoid content and phytoestrogens content, and to provide a cosmetic composition having anti-aging and skin improvement effects through increased antioxidant and hyaluronic acid production is doing

Another object of the present invention is to provide a method for anti-aging and skin improvement through increased antioxidant and hyaluronic acid production, comprising applying the cosmetic composition to a subject.

Another object of the present invention is to provide an anti-aging and skin improvement use by increasing the antioxidant and hyaluronic acid production of the cosmetic composition.

Other objects and advantages of the present invention will become more apparent from the following detailed description of the invention, claims and drawings.

One aspect of the present invention is to provide a cosmetic composition comprising, as an active ingredient, a fermented extract of a medicinal plant mixture consisting of horseback riding, angelica, cornflower oil, alfalfa and Indian gooseberry.

Horseback riding ( Cimicifugae Rhizoma) is a perennial plant, and it is the rhizome of Cimicifuga heracleifolia Komarov, Cimicifuga simplex Wormskjord, Cimicifuga dahurica Maximowicz, or Stork Ranunculaceae. In China, horseback riding is called big three-leaf horseback riding, eye horse riding is called Heungan riding, and stork riding is called horseback riding. In Japan, the rhizomes of Candelabra and other common plants are used. In oriental medicine, it has herbal effects such as relieving fever, detoxification of fever, seunggeyanggi, and fever fever. Major components include isoferulic acid, ferulic acid, caffeic acid, 27-deoxyactein, and cimicifugoside H-1. Horseback riding is known to be effective in anti-inflammatory, cancer cell proliferation inhibition, glial cell activity inhibition, gastritis and gastric ulcer inhibition, nerve cell protection, osteoporosis, and the like.

Angelicae Gigantis Radix is a plant originating from Angelicae gigias Nakai (Umbelliferae), and the root of Angelicae is used as a medicinal part. In oriental medicine, Angelica has the effects of bohyeol and hwalhyeol (補血活血), jangjangji pain (調经止痛), and yunjangtongbyeon (潤腸通便), and has the following medicinal effects. It is a summary of gynecological landscape that is used together with Sukjihwang, Countess, Chungung, etc. for menstrual relief due to hyehyeohwihwang (血虛萎黃), which has yang blood and preserving blood. It can remove various pains caused by heolheo, hyeoleo and hyeolhan, and it is used as a commercial medicine for surgery by purifying blood and turbidity. Because it has the effect of replenishing blood and regrowth, it is used by adding yukjongyong, saengsuo, hwamain, and blackmija to hyeolheo, which is the result of a weakening of the body with age or postpartum of women and menstrual constipation (腸燥便秘). The main ingredients are decusin and decusinol. These include nodakenin and demethylsuberosine. Angelica has been confirmed to have a protective effect on forebrain ischemia and suppression of glial cell activation, and is known to have cardiovascular effects such as anti-arteriosclerosis and anti-platelet aggregation and prevent osteoporosis.

Corni Fructus is a plant originating from Cornus officinalis Siebold et Zuccarini (Cornaceae), and the medicinal part uses the ripe fruit from which the seeds are removed. In oriental medicine, the medicinal properties of this drug are acid (酸) and lukewarm (微溫), and it is said that it has the effects of going into the liver and kidneys and has the effects of convergence and convergence. Its main ingredients include loganin, morroniside, Betulinic acid, and Gallic acid, and is known to be effective in inhibiting platelet aggregation, inhibiting blood vessels, and improving respiratory diseases.

Alfalfa ( Medicago sativa L. ), called alfalfa in Korea, is a perennial angiosperm belonging to the legume family, and has been cultivated as an important crop crop in many countries such as the United States, Canada, France, the Middle East, and South Africa. It has apigenin, luteolin, coumesterol, saponin, etc. as main ingredients, and it is known to improve skin and lower cholesterol levels.

Indian gooseberry ( Phyllanthus emblica L. ) is also called Emblica officinalis Gaertn or Amla and has its own name according to each region or language. It is a plant that grows wild over a wide area such as Southeast Asia including Nepal and Malaysia, as well as central and southern regions, and has components such as gallic acid, quercetin, and Ellagic acid. Efficacy is known for antioxidant, antitumor, and anti-inflammatory activity.

A mixed fermented extract of medicinal plants, which is an active ingredient of the present invention, comprises the steps of: obtaining a mixed extract by extracting horseback riding, angelica, cornflower, alfalfa and Indian gooseberry using an extraction solvent; It may be prepared by a method comprising the step of fermenting the mixed extract obtained in the above step to obtain a fermentation extract.

The mixed extract may consist of 10 to 30% by weight of horseback riding, 10 to 30% by weight of Angelica, 10 to 30% by weight of cornflower oil, 10 to 30% by weight of alfalfa, and 10 to 30% by weight of Indian gooseberry, preferably each raw material It can be used by mixing in the same amount ratio (w/w). As the extraction solvent, purified water, a lower alcohol having 1 to 4 carbon atoms, or a mixture thereof may be added thereto, but the type of solvent is not limited thereto. The extraction solvent may be used in a ratio of 1: 10 (w/w) to 1: 30 (w/w), but the ratio is not limited thereto. In addition, as the extraction method, ultrasonic extraction, heat extraction, cold extraction, reflux cooling extraction, etc. may be used, and extraction may be performed by repeating extraction once or multiple times. The extraction temperature may be 40 to 80 ℃ may be used, but is not limited thereto. The extraction time may also be used for an extraction time of 12 to 36 hours, but is not limited thereto.

Fermentation refers to the useful change of raw materials of natural products through the enzymatic action of microorganisms. A useful change here means a change such as conversion to a new active ingredient that did not exist in the raw material or increasing the active ingredient present in the raw material. Active ingredients in natural products are generally composed of compounds such as flavonoids and polyphenols , increasing their content can have an effective function on the skin. In the present invention, an increase in the active ingredient by fermentation of the mixed extract was confirmed, and the effect thereof was compared to demonstrate the increased skin improvement effect.

The mixed fermentation extract is inoculated with a fermented group at a predetermined concentration of 10 ⁵ to 10 ⁸ cells/ml in the mixed extract, and maintained at a pH of 5 to 8, a temperature of 40 to 80° C., and a humidity of 60 to 80%, depending on the conditions 24 It can be fermented by culturing for 120 hours. Lactobacillus is used as the fermenting bacteria, and Lactobacillus brevis, Lactobacillus casei, Lactobacillus casei, Lactobacillus plantarum are preferably used. not limited All the remaining cells in the resulting fermentation product are sterilized under autoclaving conditions such as autoclave. The fermented product may be filtered to obtain a mixed fermentation extract.

In the cosmetic composition of the present invention, the content of total polyphenols, total flavonoids, and ellagic acid, which is a component of phytoestrogens, is increased by the fermentation, and antioxidant activity is increased. As the antioxidant activity, radical scavenging ability and reducing power were confirmed.

In one embodiment, in the case of ellagic acid content, the extract before fermentation (extract of a medicinal plant mixture consisting of horseradish, angelica, cornflower oil, alfalfa and indian gooseberry) is 1 to 10 mg/100g, preferably 2 to 5 mg/100g, More preferably, it contains 4±0.4 mg/100g of ellagic acid, and the fermented extract of the medicinal plant mixture of the present invention obtained by the fermentation is 5 to 50 mg/100g, preferably 10 to 25 mg/100g, More preferably, it may contain 17±2 mg/100g of ellagic acid.

In addition, the present inventors have discovered a surprising fact that the fermented extract of a mixture of medicinal plants consisting of horseback riding, angelfish, cornflower oil, alfalfa and Indian gooseberry has a use for promoting skin hyaluronic acid production.

Hyaluronic acid (HA) is a water-soluble polysaccharide biopolymer with characteristics of high viscosity, moisture retention, and biocompatibility. It is known that a decrease in hyaluronic acid in the skin not only dries the skin, but also atrophys the skin volume, causing an increase in wrinkles and a decrease in elasticity of the skin. Although the antioxidant use of existing medicinal plants is well known, the use of promoting the production of hyaluronic acid in the skin is a new use different from the antioxidant use. The content of hyaluronic acid in the skin is controlled by biosynthesis by hyaluronic acid synthase and degradation by hyaluronidase. Although the effect of inhibiting the activity of hyaluronic acid degrading enzymes of existing medicinal plants has been studied, it is not enough to simply inhibit the activity of hyaluronic acid degrading enzymes for skin wrinkle improvement and significant increase in volume and elasticity, An activity that promotes the production of hyaluronic acid in the skin is required.

According to the findings of the present inventors, the fermented extract of a medicinal plant mixture consisting of horseback riding, angelica, cornflower, alfalfa and indian gooseberry has an activity to promote skin hyaluronic acid production.

In one embodiment, when the amount of hyaluronic acid produced in the keratinocytes of the skin untreated with the sample is 100%, the skin treated with the ferment extract of the medicinal plant mixture consisting of horseback riding, angelica, cornflower oil, alfalfa and Indian gooseberry of the present invention The amount of hyaluronic acid produced in keratinocytes is 110% or more, 115% or more, 120% or more, 125% or more, 130% or more, 135% or more, 140% or more, 145% or more, or 150% or more.

In addition to the hyaluronic acid production efficacy, the cosmetic composition of the present invention also exhibits an effect of inhibiting cell damage in keratinocytes of the skin caused by UV stimulation.

The sample obtained by diluting the mixed extract and the mixed fermented extract used in the present invention by 100 times does not show cytotoxicity in an experiment using human keratinocyte cell line (HaCaT).

The UVB-induced damage inhibition activity of HaCaT evaluated in the present invention is not limited thereto, and its stimulation may be applied to UVA or UVA and UVB mixing.

The cosmetic composition comprising the fermented extract of the present invention may include, in addition to the extract, conventional adjuvants and carriers such as solubilizers, stabilizers, antioxidants, vitamins, fragrances or pigments, and solutions, emulsions, suspensions, gels. , lotions, creams, pastes, powders, soaps, cleansing, oils, foundations and sprays can be prepared in any formulation conventionally prepared in the art. In more detail, it can be manufactured in the form of fermented water, nourishing lotion, flexible lotion, nourishing cream, essence, eye cream, hair tonic, hair shampoo, conditioner, cleansing cream, cleansing foam, cleansing water, body cleanser pack, spray or powder. However, the present invention is not limited thereto.

The cosmetic composition according to the present invention may further include functional additives and components included in general cosmetic compositions in addition to the fermented extract of medicinal plants. The functional additive may include, but is not limited to, a composition containing natural ingredients such as pomegranate seed oil, water-soluble vitamins, oil-soluble vitamins, polymer peptides, polymer polysaccharides, and sphingolipids.

When the formulation of the present invention is a solution or emulsion, a solvent, solubilizer or emulsifier is used as a carrier component. Examples include, but are not limited to, water, ethanol, isopropanol, ethyl carbonate, ethyl acetate, propylene glycol, 1,3-butyl glycol, glycerol aliphatic esters, polyethylene glycol or fatty acid esters of sorbitan.

When the formulation of the present invention is a suspension, as a carrier component, water, a liquid diluent such as ethanol or propylene glycol, a suspending agent such as ethoxylated isostearyl alcohol, polyoxyethylene sorbitol ester and polyoxyethylene sorbitan ester, microcrystalline Cellulose, aluminum metahydroxide, bentonite, agar or tracanth may be used, but is not limited thereto.

When the formulation of the present invention is a surfactant-containing cleansing agent, aliphatic alcohol sulfate, aliphatic alcohol ether sulfate, sulfosuccinic acid monoester, isethionate, imidazolinium derivative, methyl taurate, sarcosinate, fatty acid no De ether sulfate, alkylamidobetaine, fatty alcohol, fatty acid, glyceride, fatty acid diethanolamide, vegetable oil, lanulin derivative or ethoxylated glycerol fatty acid ester may be used, but is not limited thereto.

When the formulation of the present invention is a powder or a spray, lactose, talc, silica, aluminum hydroxide, calcium silicate or polyamide powder may be used as a carrier component, and in particular, in the case of a spray, additional chlorofluorohydrocarbon, propane and a propellant such as butane or dimethyl ether, but is not limited thereto.

When the formulation of the present invention is a paste, gel or cream, animal oil, vegetable oil, wax, paraffin, starch, tracanth, cellulose derivative, polyethylene glycol, silicone, bentonite, silica, talc or zinc oxide may be used as a carrier component. However, the present invention is not limited thereto.

Another aspect of the present invention is to provide a cosmetic comprising the cosmetic composition of the present invention described above.

The cosmetics include basic cosmetics such as mist, serum, nourishing lotion, softening lotion, soft water, emulsion, astringent, toner, skin, lotion, cream, and essence; Primer, makeup base, boomer, tone-up cream, concealer, foundation, BB cream, CC cream, tinted moisturizer, powder, compressed powder, highlighter, shading, blusher, eyebrow, eyeliner, eye shadow, mascara, rouge, lipstick , lip gloss, lip tint, and color cosmetics such as lip balm; sunscreen products such as sunscreen, sun oil, sun lotion, and sun pack; Hair treatment agent, hair clinic agent, hair nutrition agent, hair care agent, hair cleaner, shampoo, conditioner, hair tonic, hair conditioner, hair lotion, hair gel, hair pack, hair cream, hair essence, hair powder, hair spray, hair hair products such as oils, hair styling agents, post-dye treatment agents, and perms; and body products such as body lotion, body essence, body mist, body cleanser, and bath product, but is not limited thereto.

All ingredients described in the present invention, preferably, relevant laws and regulations of Korea, China, the United States, Europe, Japan, etc. (eg, regulations on cosmetic safety standards (Korea), cosmetic safety technical standards (China), Do not exceed the maximum use value prescribed by the Food Codex (Korea), Food Additives Codex (Korea), Health Functional Foods Code (Korea), etc. That is, preferably, the cosmetic or personal care composition according to the present invention contains the ingredients according to the present invention within the content limit allowed by the relevant laws and regulations of each country.

The fermented medicinal plant extract prepared by using a mixture of horseback riding, angelica, alfalfa, cornflower oil and Indian gooseberry according to the present invention increases the content of ellagic acid, a phytoestrogens, and total phenol and total flavonoids, and increases antioxidant activity It has an excellent effect on skin improvement by suppressing skin damage caused by UV rays and increasing hyaluronic acid production.

1 is a graph measuring cell viability according to UVB stimulation in HaCaT, which is a human-derived keratinocyte. UVB stimulation is the result of direct irradiation of cells with UVB at 10 mJ, and 100-fold dilution of the medicinal plant mixed extract and the medicinal plant mixed fermented extract prepared in Comparative Examples 1 and 1 and administered. Significance was examined by Student's t-test (*, p < 0.05 vs control).
2 is a graph measuring the production of hyaluronic acid produced after UVB stimulation in HaCaT, a human-derived keratinocyte. UVB was directly irradiated to the cells at 20 mJ, and the production amount was compared for 6 hours. Significance was examined by Student's t-test (*, p < 0.05 vs control).

Hereinafter, examples and the like will be described in detail to help the understanding of the present invention. However, the embodiments according to the present invention may be modified in various other aspects, and the scope of the present invention is not limited to the following examples. The embodiments of the present invention are provided in order to more completely explain the present invention by means of an average level of skill known in the art.

Example

<Comparative Example 1> Preparation of mixed medicinal plant extracts of horseback riding, Angelica, alfalfa, cornflower oil and Indian gooseberry

In this comparative example, a medicinal plant mixture composed of horseback riding, angelica, alfalfa, cornflower oil and Indian gooseberry was extracted using ultrasonic extraction. After quantifying horseradish angelfish, alfalfa, cornflower oil and Indian gooseberry, rinse with water, add 20 times the amount of distilled water, and then install a cooling condenser to prevent evaporation of the solvent and perform ultrasonic extraction for 24 hours to prepare a medicinal plant mixed extract did.

<Example 1> Preparation of fermented extracts of medicinal plants mixed with horseback riding, angelica, alfalfa, cornflower oil and Indian gooseberry

In this example, fermentation was performed using the medicinal plant mixed extract prepared in Comparative Example 1. The medicinal plant mixture extract was filled to 1/3 level in a heat sterilized container and sterilized at 121° C. for 20 minutes. The autoclaved extract was inoculated with Lactobacillus casei , Lactobacillus brevis and Lactobacillus plantarum strains 1 to 5% (w/w) at a concentration of 10 ⁶ to 10 ⁷ cell/mL, pH 6 to 8, temperature 30 to 40 ℃, and humidity 60 It was fermented by culturing for 24 to 120 hours while maintaining ~80%. The fermented product was filtered to prepare a medicinal plant fermented extract.

<Experimental Example 1> Comparison of content of ellagic acid, which is a component of phytoestrogens

In this experimental example, high-performance liquid chromatography was used to compare the content of ellagic acid contained in the mixed extract of medicinal plants and the mixed fermented extract of medicinal plants prepared in Comparative Examples 1 and 1 above.

More specifically, to prepare a standard solution, an appropriate amount of the standard material was dissolved in methanol to obtain 0.5 mg/mL to obtain a standard stock solution. The solution was dissolved by shaking, and then diluted with methanol to obtain a standard solution. To prepare the test solution, each 0.5 g of the mixed extract of medicinal plants and the mixed fermented extract of medicinal plants was precisely weighed, placed in an appropriate container, dissolved with 40 mL of methanol, and ultrasonically extracted for 1 hour. The solution was filtered through a 0.22 to 0.45 μm PTFE or PVDF membrane filter as a test solution.

As the high-performance liquid chromatography analysis conditions, an ultraviolet absorbance spectrometer (measured wavelength 370 nm) was used as the detector, and the column was used for liquid chromatography of 5 to 10 μm in a stainless steel tube with an inner diameter of 4 to 6 mm and a length of 15 to 25 cm. Octadesilyl silica gel was charged. The column temperature was a constant temperature around 40 °C, and was controlled stepwise or concentration gradient with mobile phase A and mobile phase B as mobile phases. Mobile phase A was 0.85% phosphoric acid : methanol = 6: 4 and mobile phase B was methanol. The experimental results are shown in Table 1 below.

division ellagic acid content
(mg/100g) content average
(mg/100g) Comparative Example 1-1 4.1 4.1 Comparative Example 1-2 4.2 Comparative Example 1-3 3.9 Example 1-1 17.2 17.0 Example 1-2 16.9 Examples 1-3 17.0

As shown in Table 1, it was confirmed that the content of ellagic acid in the mixed fermented extract of medicinal plants of Example 1 of the present invention was significantly increased by about 4.15 times compared to the mixed extract of medicinal plants of Comparative Example 1.

<Experimental Example 2> Measurement of total phenol and total flavonoid content

Total phenol content was determined by Folin-Ciocalteu method. In a 96-well plate, 10 μL of medicinal plant mixed extract or medicinal plant mixed fermented extract was added, mixed with 90 μL of 0.2M Folin-Ciocalteu reagent, and left at 25° C. for 5 minutes. After reacting with 100 μL of 10% sodium carbonate solution at 25°C for 30 minutes, absorbance was measured at 760 nm. With a standard calibration curve, gallic acid was confirmed at a concentration of 0 to 4 mg/mL, and the standard content of total phenol was calculated by GAE (gallic acid equivalent, μg/mL).

Total flavonoid content was measured as follows. In a 96 well plate, 10 μL of lotion and 90 μL of 0.25% NaNO ₂ were added, and reacted at room temperature for 10 minutes. 50 μL of 2% AlCl ₃ .6H ₂ O was added and reacted for 10 minutes. Then, 50 μL of 1N NaOH was added and reacted at room temperature, and absorbance was measured at 405 nm. The standard calibration curve was catechin at a concentration of 0 ~ 4 mg/mL, and the total flavonoid content of the sample was calculated as CE (catechin equivalent, μg/mL). The experimental results are shown in Table 2 below.

Metrics Comparative Example 1 Example 1 Increase rate after fermentation Total phenol content
(GAE, mg/mL) 1.38±0.02 2.83±0.11 increased to 205.3% Total flavonoid content
(CE, mg/mL) 0.85±0.03 1.54±0.03 increased to 181.1%

As shown in Table 2, the total phenol content of the mixed fermented extract of medicinal plants of Example 1 of the present invention compared to the mixed extract of medicinal plants of Comparative Example 1 was 205.3%, and the total flavonoid content was increased to 181.1%. It was confirmed that .

<Experimental Example 3> Comparison of evaluation of UV protection activity according to fermentation of mixed extracts of medicinal plants

3-1. Inhibitory activity of skin keratinocyte damage caused by UVB stimulation

In this experimental example, the protective activity according to UV stimulation in HaCaT cells, which are human-derived dermal keratinocytes, was comparatively evaluated with the mixed extracts of medicinal plants and mixed fermented extracts of medicinal plants prepared in Comparative Examples 1 and 1. HaCaT cells were cultured in DMEM medium containing 10% FBS at 37° C. and 5% CO ₂ conditions. After culturing for 24 hours in a 96-well plate at 5 x 10 ⁴ cells/mL for UV stimulation, UVB (10 mJ/cm ² ) was irradiated with a UV irradiator with the medium removed. Immediately after UV stimulation, a 100-fold diluted sample was added together with the medium, and after 24 hours of incubation, MTT assay was performed. For MTT assay, MTT solution (5 mg/mL in PBS) was diluted to a concentration of 10% in DMEM without FBS, and the cells were incubated for 30 minutes, and the resulting formazan crystal was dissolved in DMEM to measure absorbance (590 nm). .

Experimental results confirmed that the cell viability significantly decreased when UV stimulation was performed. As can be seen in Figure 1, based on the sample throughput of 10 μL, the cell viability of the mixed extract of the medicinal plant of Comparative Example 1 was 8% compared to the control, and there was little protective activity, whereas the sample of the fermented extract of the medicinal plant of Example 1 was It showed high protective activity at 90%.

3-2. Hyaluronic acid production activity of keratinocytes by UVB stimulation

In this experimental example, hyaluronic acid production activity was evaluated after UV stimulation in HaCaT cells, which are human-derived dermal keratinocytes, with the medicinal plant mixed extract and the medicinal plant mixed ferment extract prepared in Comparative Examples 1 and 1. HaCaT cells were cultured in DMEM medium containing 10% FBS at 37° C. and 5% CO ₂ conditions. After culturing for 24 hours in a 96-well plate at 5 x 10 ⁴ cells/mL for UV stimulation, UVB (20 mJ/cm ² ) was irradiated with a UV irradiator while the medium was removed. Immediately after UV stimulation, a 100-fold diluted sample was treated with DMEM medium without FBS. After culturing for 6 hours, the medium was transferred to an e-tube, centrifuged at 14,000 rpm, and hyaluronic acid present in the supernatant was measured with an ELISA kit.

The untreated group was used as a negative control group, 1.25 μL and 2.5 μL treated groups were used as the experimental group, and 1 μM of All-trans-retinoic acid (ATRA, sigma) was used as the positive control group.

As a result of calculating the amount of hyaluronic acid production with 100% of hyaluronic acid production in the sample untreated group, it was confirmed as 110% in the positive control group, and 107% and 100% in the medicinal plant mixed extract of Comparative Example 1, Example 1 In the mixed fermented extract of medicinal plants, 113% and 126% were confirmed. Therefore, in Example 1, the mixed fermentation extract of medicinal plants, it was confirmed that the hyaluronic acid production activity was significantly increased by fermentation to 113% and 126% (FIG. 2).

<Experimental Example 4> Comparison of antioxidant activity according to fermentation of fermented mixed extracts of medicinal plants

4-1. DPPH radical scavenging ability

DPPH (2,2-Diphenyl-1 picrylhydrazyl) is a stable radical, and its scavenging ability was measured as follows. DPPH was dissolved in 99.9% ethanol to 4 wt%, diluted 1:1 in DW, and filtered with a 0.4 μm syringe filter. 190 μL of the prepared DPPH solution was put into a 96 well plate, and 10 μL of each 100-fold diluted medicinal plant mixed extract and medicinal plant mixed fermented extract was added, reacted for 20 minutes, and absorbance was measured at 520 nm. For the DPPH radical scavenging ability, the absorbance value of the control was taken as 100%, and the scavenging ability was calculated with the reduced absorbance value. The experimental results are shown in Table 3 below.

measurement Comparative Example 1 Example 1 Increase rate after fermentation DPPH radical scavenging ability
(%) 43.3±10.7 81.7±5.4 increased to 188.7%

As confirmed in Table 3, the DPPH radical scavenging ability was 43.3% in the mixed extract of the medicinal plant of Comparative Example 1, and the mixed fermented extract of the medicinal plant of Example 1 was 81.7%, and the radical scavenging ability according to the fermentation was 188.7%. increased.

4-2 CUPRAC Activity Comparison

CUPRAC (cupric ion reducing antioxidant capacity) is a method for measuring the reducing power of copper ions, and was carried out as follows. A solution of 10 mM CuCl ₂ , 75 mM neocuproine in ethanol was prepared, and immediately before the experiment, it was mixed 1:1 and diluted 100-fold in DW. 190 μL of the prepared reagent was put into a 96 well plate, 10 μL of each of the medicinal plant mixed extract and the medicinal plant mixed fermented extract were put and reacted at room temperature for 30 minutes, and then absorbance was measured at 450 nm. The standard calibration curve confirmed ascorbic acid at a concentration of 0 to 0.5 mg/mL, and the reducing power of the medicinal plant mixed extract and the medicinal plant mixed fermented extract was calculated as ascorbic acid equivalent (ASE, mg/mL). The experimental results are shown in Table 4 below.

measurement Comparative Example 1 Example 1 Increase rate after fermentation reducing power
(ASE, mg/mL) 3.35±0.08 5.92±0.04 increased to 176.8%

As shown in Table 4, the copper ion reducing power was confirmed to be 3.35 mg/mL ASE of the mixed extract of the medicinal plant of Comparative Example 1, and 5.92 mg/mL of the mixed fermented extract of the medicinal plant of Example 1, and the reducing power according to the fermentation was 176.8 % level increased significantly.

The composition of the present invention can be prepared in the following formulations, and the following preparations are merely illustrative of the present invention, and thus the content of the present invention is not limited thereto.

<Preparation Example 1> Fermented lotion

A lotion containing the mixed fermented extract of medicinal plants according to Example 1 was prepared as shown in Table 5 below.

Raw material Content (wt%) 5 kinds of fermented extracts including Indian gooseberry 1.0 pomegranate seed oil 0.2 glycerin 3.0 butylene glycol 2.0 propylene glycol 2.0 Polyoxyethylene hydrogenated castor oil 0.1 ethanol 10.0 triethanolamine 0.1 preservative a very small amount Purified water remaining amount

<Preparation Example 2> Lotion

A lotion containing the mixed fermented extract of medicinal plants according to Example 1 was prepared as shown in Table 6 below.

Raw material Content (wt%) 5 kinds of fermented extracts including Indian gooseberry 1.0 pomegranate seed oil 0.2 beeswax 1.0 Polysorbate 60 2.0 sorbidan sesquioleate 0.5 liquid paraffin 10.0 Sorbidan Stearate 2.0 lipophilic monostearate glycerin 1.0 stearic acid 2.0 Glyceryl Stearate 1.5 propylene glycol 4.0 carboxy polymer 0.1 triethanolamine 0.3 antiseptic a very small amount pigment a very small amount Spices a very small amount Purified water remaining amount

<Preparation Example 3> Cream

A cream containing the mixed fermented extract of medicinal plants according to Example 1 was prepared as shown in Table 7 below.

Raw material Content (wt%) 5 kinds of fermented extracts including Indian gooseberry 1.0 pomegranate seed oil 0.2 stearic acid 2.0 cetyl alcohol 2.0 Glyceryl Monostearate 2.0 Polyoxyethylene sorbidan monosostearate 0.5 sorbidan sesquioleate 0.5 polyoxyethylene stearate 1.0 wax 1.0 floating paraffins 3.0 squalane 3.0 caprylic 3.0 Carboxyvinyl Polymer 0.2 butylene glycol 5.0 glycerin 2.5 triethanolamine 0.5 Purified water remaining amount

<Preparation Example 4> Essence

The essence containing the medicinal plant mixed fermentation extract according to Example 1 was prepared as shown in Table 8 below.

Raw material Content (wt%) 5 kinds of fermented extracts including Indian gooseberry 1.0 pomegranate seed oil 0.2 sitosterol 2.0 Polyglyceryl 2-oleate 1.5 ceramide 1.0 Steares-4 1.5 cholesterol 2.0 dicetyl phosphate 0.5 concentrated glycerin 5.0 macadamia oil 20.0 Carboxyvinyl Polymer 0.3 Xanthan Gum 0.3 antiseptic a very small amount Spices a very small amount Purified water remaining amount

Those of ordinary skill in the art to which the present invention pertains, in addition to the preparation examples listed above, according to conventional formulations known in the art, various cosmetic compositions containing the medicinal plant mixed fermentation extract according to Example 1 can be prepared. will clearly understand

Claims (8)

A cosmetic composition comprising, as an active ingredient, a fermented extract of a mixture of medicinal plants consisting of horseback riding, angelica, cornus oil, alfalfa and Indian gooseberry. The method according to claim 1, wherein the medicinal plant mixture is 10 to 30% by weight of horseback riding, 10 to 30% by weight of Angelica, 10 to 30% by weight of cornflower oil, 10 to 30% by weight of alfalfa, and 10 to 30% by weight of Indian gooseberry. A cosmetic composition comprising The cosmetic composition according to claim 1, wherein the fermented extract of the medicinal plant mixture is fermented by inoculating the extract of the medicinal plant mixture with a Lactobacillus genus lactic acid strain. The cosmetic composition according to claim 3, wherein the fermented extract of the medicinal plant mixture has an increased content of phytoestrogens compared to the extract of the medicinal plant mixture before fermentation. The cosmetic composition according to claim 1, wherein the cosmetic composition has one or more uses selected from antioxidant use, hyaluronic acid production, and UV-induced skin damage inhibition. The cosmetic composition according to claim 1, wherein the cosmetic composition further comprises pomegranate seed oil. A cosmetic comprising the cosmetic composition according to any one of claims 1 to 6. The cosmetic according to claim 7, wherein the cosmetic is selected from basic cosmetics, color cosmetics, sunscreen products, hair products, and body products.

Images